Shed vs Telos Rx: Coaching, Pricing, and Medication Options
Shed vs Telos Rx: quick verdict. If you want integrated coaching and the option to choose name-brand or compounded GLP-1, Shed is the clearer fit. If your priority is lower advertised starting prices for compounded semaglutide or tirzepatide, Telos Rx shows lower “as low as” monthly pricing when a licensed provider approves you.
Explore Shed plans and coaching
How Shed and Telos Rx differ at a glance
The comparison below focuses on the most distinctive supported differences: medication types offered, coaching and care model, advertised starting prices, speed and process of approval, and regulatory notes about compounded medications. All facts follow the supplied evidence.
Direct comparison table
| Criteria | Shed | Telos Rx |
|---|---|---|
| Medication types | Offers both FDA-approved name-brand GLP-1 and compounded GLP-1 options | Offers compounded semaglutide and compounded tirzepatide |
| Coaching and clinical support | Integrated continuous coaching included in treatment | No integrated coaching claimed in the captured evidence |
| Advertised starting price | Compounded semaglutide starting at $199 per month; compounded tirzepatide starting at $299 | Semaglutide as low as $99 per month; tirzepatide as low as $139 per month, if approved |
| Approval process timing | 2-minute approval assessment, then clinician review | Subject to review and approval by a US-licensed provider |
| Regulatory note | Compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness or quality |
Medication options and regulatory status
Shed and Telos Rx both offer access to compounded GLP-1 medications, and Shed additionally advertises FDA-approved name-brand GLP-1 options. The evidence for Shed states explicitly that name-brand options are available alongside compounded choices, while Telos Rx emphasizes compounded semaglutide and tirzepatide. Both sources include the regulatorily precise note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Coaching and care model
Shed positions itself as a platform that pairs medication with continuous coaching so treatment is not “just a script.” The captured evidence describes integrated coaching and a thesis that medication alone is often insufficient. The Telos Rx evidence does not show an integrated coaching model in the captured material. That difference is a primary distinction between the two providers supported by the supplied facts.
See Shed coaching and medication choices
Pricing and what “starting” or “as low as” means here
Both providers publish advertised starting or as low as monthly numbers, with different messaging. Shed lists compounded semaglutide starting at $199 per month and compounded tirzepatide starting at $299 per month, and offers 10% off your first month. Telos Rx advertises semaglutide as low as $99 per month and tirzepatide as low as $139 per month, with the condition that a US-licensed provider must approve you. The evidence for Telos Rx also notes “Pay $0 if not approved” in the captured landing-page content. Neither source supplies a complete standard pricing table for every plan variation in the captured evidence, and Shed states standard pricing is personalized after intake.
Approval, eligibility and timing
Shed advertises a 2-minute online assessment to check eligibility, followed by a clinician review before prescription. Telos Rx specifies prescriptions are issued only after review by a US-licensed provider. Both require clinician review before medication is prescribed. Timing beyond the initial assessment is not detailed for Telos Rx in the captured evidence.
What each provider emphasizes most
Shed emphasizes choice between name-brand and compounded GLP-1 and continuous coaching, plus a 2-minute assessment and 10% off the first month. Telos Rx emphasizes lower “as low as” monthly pricing for compounded semaglutide and tirzepatide and clinician review to determine the right molecule for you.
Check Telos Rx compounded pricing
Comparison summary and final thoughts on Shed vs Telos Rx
For a direct comparison: Shed offers both name-brand and compounded GLP-1 plus integrated coaching and a quick assessment, with compounded semaglutide starting at $199 per month and a 10% first month offer. Telos Rx offers compounded semaglutide as low as $99 per month and compounded tirzepatide as low as $139 per month when a US-licensed provider approves you. Both note that compounded medications are not FDA-approved. Use these distinctions to match priorities.
Start Shed intake and view membership options
Begin Telos Rx eligibility check
Choose one if
Choose Shed if you want the option of FDA-approved name-brand GLP-1 plus compounded alternatives and integrated, continuous coaching, with a 2-minute assessment and a 10% off first month offer.
Choose Telos Rx if your main priority is access to compounded semaglutide or tirzepatide at the advertised as low as monthly prices and you confirm eligibility and approval by a US-licensed provider.